Product Description: Lasrekibart is a humanized monoclonal antibody targeting human interleukin 5 (IL-5). Lasrekibart specifically binds to IL-5, blocking the interaction between IL-5 and its receptor, thus exerting immunosuppressive and anti-inflammatory activities. Lasrekibart is promising for research of allergic and inflammatory diseases, such as asthma[1].
Applications: COVID-19-immunoregulation
Formula: N/A
References: [1]World Health Organization. WHO Drug Information: Volume 38[M]. World Health Organization, 2024.
CAS Number: 3021525-26-5
Molecular Weight: N/A
Research Area: Inflammation/Immunology
Target: Interleukin Related